Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lumatix Biotech is a bioprocessing technology company based in Garching, Germany, that focuses on the purification of complex biologics. The company has developed a proprietary light-controlled affinity chromatography platform designed to replace traditional chemical elution methods. By using light to trigger the release of target molecules from ligands, the technology avoids the use of extreme pH levels or high salt concentrations that can damage sensitive proteins. This innovation aims to improve the stability, activity, and yield of therapeutic antibodies and other recombinant proteins during downstream processing. As a spin-off from the Technical University of Munich, Lumatix Biotech provides tools and services to streamline pharmaceutical manufacturing and reduce production costs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lumatix Biotech.